Abstract
Despite good results of polychemotherapy in head and neck cancer, monochemotherapy retains a valuable role in managing patients with advanced disease. In a palliative setting, lower toxicity and simpler handling of therapy with single agents are outlined by the Authors, who review results of most active drugs in their different schedules.
Original language | English |
---|---|
Pages (from-to) | 303-309 |
Number of pages | 7 |
Journal | Chemioterapia |
Volume | 4 |
Issue number | 4 |
Publication status | Published - 1985 |
ASJC Scopus subject areas
- Microbiology (medical)
- Pharmacology (medical)